eschbach's Shiftconnector® Helps Power Merck's Visual Factory to Drive Greater Transparency, Agility, and Supply Chain Resilience 23 October
Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025 23 October
FDA Grants Priority Review for KEYTRUDA® and KEYTRUDA QLEX , Each in Combination with Padcev® , for Certain Patients with Muscle-Invasive Bladder Cancer 23 October